IL1B and metabolic dysfunction-associated steatohepatitis: Then ERK1/2 can activate NF-κB by stimulating IKK, causing the release of inflammatory factors, such as TNF-α and IL-1β, and promoting the development of NASH (Lee et al., 2017; Cai et al., 2018).